0.0%
RETA-30Metabolic & Weight
GLP-3 Reta
Retatrutide is a triple GIP/GLP-1/Glucagon receptor agonist, the first of its class, delivered in a once-weekly prefilled Klik-pen.
Select variant
AED 950
Benefits
- Weight reduction
- Reducing appetite
- Slowing digestion
- Metabolic regulation
- Body composition optimization
Important
Retatrutide (LY3437943) - triple GIP/GLP-1/glucagon agonist. 30mg pen, reconstitute with 2.4-3ml bacteriostatic water.
Click guide (30mg pen)
- 8 clicks = 1mg
- 16 clicks = 2mg
- 24 clicks = 3mg
- 32 clicks = 4mg
- 40 clicks = 5mg
Studies showed that taking it once a week is enough to see results.
Cycle
Once weekly. Follow a structured on/off protocol.
Research background
GLP-3 Reta contains retatrutide (LY3437943), a novel triple-acting receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Each pen contains 30mg/2.4ml (4 doses of 7.5mg). The glucagon receptor component adds thermogenic and lipolytic effects beyond what dual agonists achieve. Phase 2 clinical data demonstrated unprecedented weight reduction of up to 24% at 48 weeks. Research focuses on obesity, NASH/MAFLD, and metabolic syndrome.
Related compounds
AOD-5→
AOD
In stockAOD-9604 is a modified fragment of human growth hormone (hGH 176-191) researched for fat metabolism without growth-promoting effects, delivered in a prefilled Klik-pen.
AED 650
AICAR-50→
CAR
In stockAICAR is an AMPK activator researched as an exercise mimetic and metabolic regulator, delivered in a prefilled Klik-pen.
AED 500
RETA2-35→
GLP-4 Reta
In stockGLP-4 Reta combines Retatrutide 30mg and Cagrilintide 5mg in a single prefilled Klik-pen for multi-pathway metabolic research.
AED 1,200